Thymic Carcinoma
📧 Sign up to get email alerts when something new happens for Thymic Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-27Clinical Trial Update: Postoperative Adjuvant Chemotherapy for Thymic Cancer (FUSCC-Thymic 3) [Phase 3]
Phase 3 trial update evaluating postoperative adjuvant chemotherapy for thymic cancer (FUSCC-Thymic 3) is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-04-07Clinical Trial Update: PT-112 in Subjects With Thymoma and Thymic Carcinoma [Phase 2]
A Phase 2 clinical trial evaluating PT-112 in patients with thymoma and thymic carcinoma is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-03-23Clinical Trial Update: Pembrolizumab and Sunitinib Malate in Treating Participants With Refractory Metastatic or Unresectable Thymic Cancer [Phase 2]
A Phase 2 clinical trial update examining pembrolizumab in combination with sunitinib malate for refractory metastatic or unresectable thymi…
-
CLINICAL_TRIALS trial_result · 2026-03-18Clinical Trial Update: Neoadjuvant Adebrelimab Plus CRT for Locally Advanced Thymic Carcinoma [Phase 2]
This Clinical Trial Update describes a Phase 2 neoadjuvant trial of adebrelimab plus chemoradiotherapy for locally advanced thymic carcinoma…
-
CLINICAL_TRIALS trial_result · 2026-02-19Clinical Trial Update: Combination of Pembrolizumab and Lenvatinib, in Pre-treated Thymic CArcinoma paTIents [Phase 2]
A Phase 2 trial evaluating the combination of pembrolizumab and lenvatinib in pre-treated thymic carcinoma and thymoma Type B3 has completed…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-01-06Clinical Trial Update: A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced Cancers [Phase 1]
Phase 1 study assessing safety and early efficacy of KFA115 alone and in combination with pembrolizumab in select advanced cancers; the tria…
-
CLINICAL_TRIALS trial_result · 2025-10-30Clinical Trial Update: Carboplatin and Paclitaxel With or Without Ramucirumab in Treating Patients With Locally Advanced, Recurrent, or Metastatic Thymic Cancer That Cannot Be Removed by Surgery [Phase 2]
Phase 2 trial evaluating carboplatin and paclitaxel with or without ramucirumab in thymic carcinoma has completed; results have been posted.
-
CLINICAL_TRIALS trial_result · 2025-09-17Clinical Trial Update: Survival Nomogram for Patients With Thymic Carcinoma [NA]
This clinical trial update reports on a survival nomogram study for patients with thymic carcinoma. The trial has completed.
-
CLINICAL_TRIALS trial_result · 2024-10-08Clinical Trial Update: Phase I/II Eval Safety & Prelim Activity Nivolumab Comb W/Vorolanib Pts W/Refractory Thoracic Tumors [Phase 1, Phase 2]
Phase I/II trial evaluating the safety and preliminary activity of nivolumab combined with vorolanib in patients with refractory thoracic tu…
-
CLINICAL_TRIALS trial_result · 2024-06-11Clinical Trial Update: A Study to Investigate the Efficacy and Safety of Atezolizumab (Tecentriq) in Previously-Treated Patients With Advanced Thymic Carcinoma [Phase 2]
Atezolizumab (Tecentriq) was studied in a Phase 2 trial for efficacy and safety in previously treated advanced thymic carcinoma. The trial h…
-
CLINICAL_TRIALS trial_result · 2024-05-29Clinical Trial Update: Ramucirumab and Carbo-Paclitaxel for Untreated Thymic Carcinoma / B3 Thymoma With Carcinoma (RELEVENT) [Phase 2]
Phase 2 trial RELEVENT evaluates ramucirumab with carboplatin and paclitaxel for untreated thymic carcinoma or B3 thymoma with carcinoma. Th…
-
CLINICAL_TRIALS trial_result · 2024-04-16Clinical Trial Update: A Study of KN046 in Patients With Thymic Carcinoma Who Failed Immune Checkpoint Inhibitors [Phase 2]
Phase 2 trial of KN046 in thymic carcinoma patients who failed prior immune checkpoint inhibitors has been terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2023-09-06Clinical Trial Update: Neoadjuvant Treatment For Locally Advanced Thymic Cancer [Phase 2]
Phase 2 trial update on neoadjuvant treatment for locally advanced thymic cancer.
-
CLINICAL_TRIALS trial_result · 2023-06-15Clinical Trial Update: Octreotide With or Without Prednisone in Treating Patients With Metastatic or Recurrent Thymoma [Phase 2]
Phase 2 trial evaluating octreotide with or without prednisone for metastatic or recurrent thymoma/thymic carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2023-04-11Clinical Trial Update: Molecular Profiling and Targeted Therapy for Advanced Non-Small Cell Lung Cancer, Small Cell Lung Cancer, and Thymic Malignancies [Phase 2]
A Phase 2 trial evaluating molecular profiling-guided targeted therapy across advanced non-small cell lung cancer, small cell lung cancer, a…
-
CLINICAL_TRIALS trial_result · 2023-02-21Clinical Trial Update: Nivolumab in Patients With Type B3 Thymoma and Thymic Carcinoma (NIVOTHYM) [Phase 2]
Phase 2 trial update of nivolumab in patients with Thymoma Type B3 and thymic carcinoma.
-
CLINICAL_TRIALS trial_result · 2022-09-10Clinical Trial Update: Study of Everolimus in Patients With Thymoma and Thymic Carcinoma Previously Treated With Chemotherapy [Phase 2]
Phase 2 clinical trial evaluating everolimus in thymoma and thymic carcinoma patients previously treated with chemotherapy has completed.
-
CLINICAL_TRIALS trial_result · 2022-09-10Clinical Trial Update: Regorafenib in Patients With Metastatic Solid Tumors Who Have Progressed After Standard Therapy [Phase 2]
Phase 2 trial evaluating regorafenib in metastatic solid tumors that progressed after standard therapy has completed, with multiple indicate…
-
CLINICAL_TRIALS trial_result · 2021-12-10Clinical Trial Update: Hypofractionated Chemoradiotherapy and Thymosin α1 in Unresectable or Recurrent Thymic Epithelial Tumor [Phase 2]
Phase 2 trial evaluating hypofractionated chemoradiotherapy with Thymosin α1 for unresectable or recurrent thymic epithelial tumors (thymoma…
-
CLINICAL_TRIALS trial_result · 2021-06-09Clinical Trial Update: Trial of Sunitinib in Patients With Type B3 Thymoma or Thymic Carcinoma in Second and Further Lines (Style Trial) [Phase 2]
Phase 2 trial evaluating sunitinib in patients with Type B3 thymoma or thymic carcinoma in second and later lines; status currently UNKNOWN.
-
CLINICAL_TRIALS trial_result · 2020-10-28Clinical Trial Update: Chemotherapy Combined With Pembrolizumab in Treating Patients With Thymoma and Thymic Carcinoma [Phase 4]
Phase 4 trial update evaluating chemotherapy combined with pembrolizumab for thymoma and thymic carcinoma.
-
CLINICAL_TRIALS trial_result · 2019-12-13Clinical Trial Update: Pembrolizumab and Epacadostat in Patients With Thymic Carcinoma [Phase 2]
Phase 2 trial evaluating pembrolizumab with epacadostat in thymic carcinoma to assess efficacy and safety.
-
CLINICAL_TRIALS trial_result · 2019-01-23Clinical Trial Update: A Study of Sunitinib in Patients With Metastatic or Recurrent Thymic Carcinoma [Phase 2]
Phase 2 study evaluating Sunitinib in patients with metastatic or recurrent thymic carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2018-10-16Clinical Trial Update: Phase II Study Of Oral PHA-848125AC In Patients With Thymic Carcinoma [Phase 2]
A Phase II trial of oral PHA-848125AC in thymic carcinoma was terminated. The results were posted in 2018.
-
CLINICAL_TRIALS trial_result · 2017-06-16Clinical Trial Update: Genetic Evaluation of Families With Endocrine Cancers
This completed clinical trial evaluates genetic factors in families with endocrine cancers, including pancreatic cancer, thymic carcinoma, h…